Skip to main content

2 Result(s)

within Robert M. Samstein Remove this filter English Remove this filter Biomedicine, general Remove this filter Infectious Diseases Remove this filter

and
Your search also matched 4 preview-only Content is preview-only when you or your institution have not yet subscribed to it.

By making our abstracts and previews universally accessible we help you purchase only the content that is relevant to you. results, e.g.

Immunogenic neoantigens derived from gene fusions stimulate T cell responses

Include preview-only content

  1. Article

    Open Access

    Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

    Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr… in Nature Medicine (2024)

    Download PDF (598 KB) View Article

  2. Article

    Open Access

    Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

    Cystectomy is a standard treatment for muscle-invasive bladder cancer (MIBC), but it is life-altering. We initiated a phase 2 study in which patients with MIBC received four cycles of gemcitabine, cisplatin, p...

    Matthew D. Galsky, Siamak Daneshmand, Sudeh Izadmehr… in Nature Medicine (2023)

    Download PDF (5378 KB) View Article